Changes in intestinal microbiota in patients with pancreatic cancer: a systematic review and meta-analysis

Meng Liang,Zheng Liu,Rui Zhang,Jihye Yang,Xiao-Wei Wang,Nan Zhang

Published 2025 in Frontiers in Microbiology

ABSTRACT

Background Pancreatic cancer (PC) is a highly aggressive malignancy with an asymptomatic early stage, often resulting in rapid invasion of adjacent tissues and organs and a high mortality rate. Recent research has increasingly examined the gut microbiome as a potential factor in PC pathogenesis. Although changes in gut microbiota composition have been reported in patients with PC, a comprehensive evaluation of the relationship between gut microbiota and PC has not been systematically conducted. Methods A systematic search of PubMed, Web of Science, Embase, and Cochrane databases was conducted, and a meta-analysis was performed on 10 studies including a total of 324 patients with PC. Results The meta-analysis did not identify a statistically significant difference in α-diversity and microbial richness between patients with PC and those in the control group. However, a decrease in Bacteroides, Neisseria, Porphyromonas, Prevotella, and Actinomyces was observed in patients with PC, while Fusobacterium, Rothia, Streptococcus, Veillonella, and Escherichia-Shigella levels were increased. Conclusion This meta-analysis demonstrates an association between PC and changes in gut microbiota composition at both the species and genus levels. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/recorddashboard, identifier CRD42023468159.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-37 of 37 references · Page 1 of 1

CITED BY

  • No citing papers are available for this paper.

Showing 0-0 of 0 citing papers · Page 1 of 1